KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Gross Profit: 2014-2024

Historic Gross Profit for BeOne Medicines (ONC) over the last 10 years, with Dec 2024 value amounting to $3.2 billion.

  • BeOne Medicines' Gross Profit rose 46.28% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year increase of 54.31%. This contributed to the annual value of $3.2 billion for FY2024, which is 54.71% up from last year.
  • BeOne Medicines' Gross Profit amounted to $3.2 billion in FY2024, which was up 54.71% from $2.1 billion recorded in FY2023.
  • BeOne Medicines' 5-year Gross Profit high stood at $3.2 billion for FY2024, and its period low was $238.2 million during FY2020.
  • In the last 3 years, BeOne Medicines' Gross Profit had a median value of $2.1 billion in 2023 and averaged $2.1 billion.
  • Data for BeOne Medicines' Gross Profit shows a peak YoY surged of 324.56% (in 2021) over the last 5 years.
  • Over the past 5 years, BeOne Medicines' Gross Profit (Yearly) stood at $238.2 million in 2020, then surged by 324.56% to $1.0 billion in 2021, then climbed by 11.67% to $1.1 billion in 2022, then surged by 84.06% to $2.1 billion in 2023, then skyrocketed by 54.71% to $3.2 billion in 2024.